KATERYNA KUZMYCHOVA: Open Payments
NPI 1447819172 · EVERETT, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 12 payments from 7 companies in 2025. Trend: 2023 $585 · 2024 $498 · 2025 $653
Food & beverage: $538Consulting: $115
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $264 |
| Alkermes, Inc. | 3 | $172 |
| Janssen Scientific Affairs, LLC | 1 | $115 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $14 |
Products named: Auvelity, LYBALVI, SPRAVATO, ARISTADA, COBENFY, AUSTEDO XR, Jornay PM, VRAYLAR.
Industry payments across WA — which companies pay providers there.
